Advaita Bio Launches iSCanGuide for Unified Single Cell and Spatial Transcriptomics Analysis

May 7, 2026
Advaita Bio has introduced iSCanGuide, a cloud platform that integrates single cell and spatial transcriptomics data analysis into a unified GPU-accelerated environment, reducing processing times from weeks to minutes.

Advaita Bio has introduced iSCanGuide, a cloud platform for analyzing single cell and spatial transcriptomics data, announced in a press release. The platform is designed to convert large biological datasets into interpretable results using a GPU-accelerated infrastructure.

iSCanGuide integrates with Advaita's existing iPathwayGuide platform and replaces fragmented data workflows with a unified research environment. Researchers can perform analyses that previously required weeks of manual processing in a matter of minutes.

The system builds on two decades of validated research used in Advaita's pathway analysis tools, which are already trusted by over 13,000 scientists worldwide.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.